Blog posts

BERKELEY, Calif. and MAINZ, Germany and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz'' or the “Company”), a molecular genetics diagnostic company specializing in the...

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, today announced that members of its management team will participate in the Canaccord Genuity...

The partnership aims to enable universal access to genomic-driven wellness and longevity   June 22, 2022   Emirates Post, the official postal operator and leading express provider in the UAE,...

MILAN, Italy, June 06, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, partners with GetFIT Lifestyle, the first Italian fitness group, to offer Dante’s Scientific...

NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, highlights significant progress made in its drug discovery development program with six drug candidates...

Dante Labs is a Global Leader in Genomics and Precision Medicine Mainz is Exclusively Focused on Developing Next Generation Diagnostics for the Early Detection of Cancer     BERKELEY, Calif....